Point6 Bio is a computational biology company, focused on capturing multi-omics molecular insights from the proteome, including from the subject’s gut microbiome, to identify biomarker signatures, which will eventually affect treatment decisions and new drug targets identification in Autism.

By harnessing computational and systems biology, the company captures multi-omics molecular insights, aimed at driving a paradigm shift for families and transforming ASD care.Its platform integrates advanced AI with multi-omic data to detect subtle but critical molecular changes underlying neurodevelopmental disorders.By decoding proteomic and post-translational modification (PTM) patterns from simple blood samples, the platform identifies reproducible, disease-specific biomarker signatures that enable early, reliable diagnosis.